–
Aptevo Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−21.4
FY22:
−28.6
FY23:
−28.9
FY24:
−24.6
FY25:
−26.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.3
FY22:
−27.7
FY23:
−38.0
FY24:
−24.3
FY25:
−26.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.4
FY22:
7.01
FY23:
−18.7
FY24:
−24.1
FY25:
−26.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.5
FY22:
8.03
FY23:
−17.4
FY24:
−24.1
FY25:
−26.0
All amounts in millions USD